Assesses vibrotactile therapy's effect on bradykinesia in Parkinson's patients, suggesting therapeutic potential.
The present research examines a novel non-invasive vibrotactile device which stimulates fingertips in a pattern aiming to disrupt pathological physiological beta-band oscillations associated with motor symptoms, particularly bradykinesia, of Parkinson’s Disease (PD). Specifically, we assess whether the therapy reduces symptoms of bradykinesia compared to a sham control of general vibrotactile (VT) stimulation.
No takes yet. Share an insight, caveat, or question.
Kabasenche et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: